Is Inhibrx Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: INBX) stock is to Buy INBX stock.
Out of 2 analysts, 0 (0%) are recommending INBX as a Strong Buy, 2 (100%) are recommending INBX as a Buy, 0 (0%) are recommending INBX as a Hold, 0 (0%) are recommending INBX as a Sell, and 0 (0%) are recommending INBX as a Strong Sell.
What is INBX's forecast return on equity (ROE) for 2023-2023?
(NASDAQ: INBX) forecast ROE is N/A, which is considered weak.
What is INBX's Price Target?
According to 2 Wall Street analysts that have issued a 1 year INBX price target, the average INBX price target is $31.00, with the highest INBX stock price forecast at $35.00 and the lowest INBX stock price forecast at $27.00.
On average, Wall Street analysts predict that Inhibrx's share price could reach $31.00 by Aug 23, 2024. The average Inhibrx stock price prediction forecasts a potential upside of 77.55% from the current INBX share price of $17.46.
What is INBX's forecast return on assets (ROA) for 2023-2023?
(NASDAQ: INBX) forecast ROA is -90.75%, which is lower than the forecast US Biotechnology industry average of -4.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.